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S_nary Children (0- 14 years) with malignant brain and central nervous system (CNS) tumours (ICD9 191
and 192) were listed from the Scottish Cancer Registration Scheme for the years 1975-90. These cases formed
the basis for validation and verification procedures aimed at providing a complete and accurate data set for
epidemiological analyses. A variety of data sources were cross-checked to optimise ascertainment, and
resulting from this 5.7% of validated cases were found on the cancer registry with diagnostic codes outside the
ICD-9 range 191-192. A further 8.4% were newly registered cases. Analyses were conducted on the validated
data set showing a significant temporal increase in incidence rates over the 16 year study period with an
average annual percentage change of + 2.6%. Large-scale geographical heterogeneity was also found, with a
particularly high incidence in the Fife and Lothian areas and a low incidence in Grampian. Examination of
associations with socioeconomic status, using the Carstairs deprivation index, revealed a rising trend in
incidence strongly linked to areas with increasing levels of affluence. Our results suggest that for studies of
childhood CNS tumours validation of cancer registry data is necessary and large-scale geographical variation
and socioeconomic factors should be taken into account in any investigation of distribution in small
geographical areas.
Recent technological advances in a range of diagnostic tech-
niques have made the identification of tumours in the brain
and central nervous system potentially more complete and
accurate. However, temporal trends in the incidence of brain
tumours are sparsely documented for children and young
people, and international variation shows inconsistent trends
(Davis et al., 1990, Mao et al., 1991). Suggested increases in
incidence must be interpreted in relation to the impact of
improved diagnostic techniques on the ascertainment of
cases.
As a preliminary to a geographical study investigating the
incidence of childhood cancer near nuclear facilities in Scot-
land, a validation exercise was initiated to provide an optimal
data set in terms ofcompleteness and accuracy. This involved
cross-checking of alternative sources of ascertainment, valida-
tion of diagnosis and verification of case details. As part of
this exercise the incidence and pathology of central nervous
system (CNS) tumours in children in Scotland between 1975
and 1990 have been reviewed.
The main source of data for the study was the Scottish
National Cancer Registration Scheme (SMR6). The two aims
of this paper are to assess the completeness and accuracy of
the original cancer registration data for childhood CNS
tumours and, for the validated data set, to describe the
incidence and broad geographical distribution in Scotland.
Data and methods
Data
A listing of all registrations of malignant CNS tumours
(ICD-9 codes 191 and 192) in children aged 0-14 diagnosed
in Scotland in 1975-90 was obtained from the Scottish
National Cancer Registration Scheme. This included inform-
ation on the diagnosis [tumour site and morphology coded to
ICD-9 (WHO, 1977) and ICD-O (WHO, 1976) respectively]
and case details such as the child's name, data of birth, post
code of residence and hospital of treatment. In order to
assess the completeness of ascertainment of the registry, com-
puterised data linkage procedures were undertaken to com-
pare the cancer registration case listing with the Scottish
Morbidity Record for Inpatients (SMR1) and the UK
National Registry of Childhood Tumours (Draper et al.,
1988). The linkage procedure matched data files on surname,
initial, date of birth and post code sector. Exact matches
were disregarded and mismatches examiined manually to
establish the presence of potential new cases. The linkage
resulted in a number of apparently unregistered cases which
were added to the study data set.
For each cancer registration and potential new case a form
was created showing initial diagnosis and case details and
was passed to the collaborating pathologist (J.W.I.). The
form was structured in order to permit the pathologists to
indicate whether or not a particular item of cancer registra-
tion information could be verified and to record any amend-
ments. During the course of searching hospital and
pathology records the participating pathologists identified
further potential cases. These were included in the study and
submitted for formal review.
Pathologists were asked to record if slides had been
available for the case review and to submit written diagnoses
which were coded to ICD-9, ICD-O, ICD-10 (WHO, 1992)
and ICD-02 (Percy et al., 1990). For the purposes of the
epidemiological review, cases were also classified according to
the Childhood Cancer Research Group (CCRG) modification
(C.A. Stiller, personal communication) of the Birch and
Marsden (1987) classification. Age-specific population
estimates for health board areas and Scotland were
abstracted from annual reports of the Registrar General
Scotland (Registrar General Scotland, 1975-90).
Statistical methods
Trends in incidence were examined by calculating age stan-
dardised rates, using the direct method (Boyle et al., 1991)
and the world standard population (Muir et al., 1987).
Incidence rates throughout are expressed per million years of
childhood (0-14 years) population. Average annual percen-
tage changes in incidence were estimated by fitting regression
lines to the logarithms of the age-standan'sed rates for the
years 1975-90. Standarised registration ratios (SRRs) with
95% confidence intervals (Breslow & Day, 1987) were used
to compare incidence in the health board areas of Scotland.
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Carstairs deprivation scores of post code sectors based on
socioeconomic variables from the 1981 census (Carstairs &
Morris, 1991) were used to study variations in incidence with
socioeconomic status.
Pathological review
This component of the study aimed to identify correct
pathological diagnoses in addition to reviewing case notes for
confirmation ofdemographic details. Paricular attention was
focused on name, date of birth and address at time of
iagnosis; differences were recorded on a standard form. Tbe
orginal cancer registration data inchlded the name of each
patient, the hospital in which the diagnosis was made and
year of dignosis. From this information, cases were traced
to the four neurosurgical units in Scotland, and the files of
the corresponding neuropathology laboratories were
systematially searched to identify the biopsy material, where
available, and the address of each patient at time of diag-
nosis. Where no information was obtained, case notes were
retrieved and examined in order to obtain the information
required for the review, and to establish whether or not a
biopsy procedure or autopsy had been performed. Unbiop-
sied cases had their method of diagnosis (e.g. radiological
examination) noted and were coded as 'not histologally
verified'.
The histological sections from the neuropathology files
were reviewed in each case by J.C.A. and J.W.I., and the
diagnoses classified according to the revised WHO
classifation (Kleihues et al., 1993) corresponded closely to
those in ICD-10. For the purposes of the current study
primitive neuroectodermal tumours (PNET) at any site were
coded to medulloblastomas. In cases of difficulty, after dis-
cussion with the ocal neuropathologist, additional paraffin
sections were cut and further histological investigations (m-
chxling immunocytochemistry) were performed in order to
clarify the diagnosis. In cases where no file slides were
available, tissue blocks were retrieved and routinely stained
preparations were eamine in the first instance. Additional
investigations were required in approximately 15% of cass,
most of which originated from the earlier part of the review
period before immunocytochenistry had become an estab-
lished diagnostic tool in neuropathology.
In addition, diagnostic files of each of the four
neuropathology laboratorie were systematicaly searched for
childhood cases under individual tumour categories over the
years of the review period for medulloblastomas, epen-
dymomas, pilocytic astrocytomas, brain stem gliomas,
teratomas and germinomas. Biopsy numbers and patient
names were compared with those provided from the cancer
registration data, and any additional cases were identified
and reviewed. Additional information on these cases was
obtaied from hospital case notes, and the appopriate regis-
tration information was extracted and entered into the study.
In cases where an inappropriate registration had occurred
on grounds of the pathology, a revised diagnosis was made
and the registration data amended accordingly.
Resut
Ascertainment
The original data extraction from the Scottish Cancer Regis-
tration Scheme (SMR6) comprised 400 brain tumours (ICD-9
191) and 42 other central nervous system tumours (ICD-9
192). The verification procedures identified eight cases which
failed to satisfy the study criteria. Of these, two cases were
first diagnosed while resident outside Scotland, four were
duplicate registrations, one was aged older than 14 at diag-
nosis and one had been first diagnosed before 1975 (see
Table I). In five cases, no confirmatory information could be
found and these, along with the eight described above, were
excluded from the case review. This left 429 cases (390 coded
to brain and 39 to other CNS) which formed the
denominator for assessing the accuracy of case details and
dagnosis noted in the cancer registration scheme.
Data linkage procedures idtified 53 possible additional
cases, but only 15 of these were subsequently confirmed.
Collaborating pathologists identified a further 26
unregistered cases, giving a total of41 confirmed cases which
had not been registered 8.4%, 41/487). A further 28
confirmed cases (5.7%, 28/487) were identified from
pathological reviews of other diagnostic groups (i.e. cases
registered under codes other than ICD-9 191-192), these had
been inappropriately registered as follows: one eye tumour,
seven malignant neoplasms of other endocrine glands and
related structures, 12 neoplasms of uncertain behaviour of
endocrine glands and nervous system; one case had been
coded to connective and other soft tissue (ICD 171) and
seven to neoplasms of unspecified nature. Table I details the
newly ientified cases which were added to the data set for
the pathologcl rview. The five cases for which no case
notes or pathology records could be found were also added
to the analysis data set, giving a total of 487, of which 442
orginated from the cancer registration listing.
Accuracy ofcancer registration data
Numbers and percentages of errors found for the main data
items of interest for the 429 original cases submitted for
Table I Summary of case verification, validation and ascertain-
ment
Cases exchlded from original total of
First d d whie resident outside Scotland
Duplicate registrations
Age> 14 at diagnois
First diagnosed before 1975
Subtotal
442
2
4
1
434
No verification of case details or validation possible
Total cases submitted for pathologkal review
Registered diagnosis not valid in ICD-9 range 191-192
Total validated cases in ICD-9 range 191-192
New cases identified from
Linkage with SMRI
Linkag with CCRG
Patholois notfications
Other ICD-9 diagnosis groups
Subtotal
5
429
16
413
11
4
26
28
482
Unvalidated cases reintroduced 5
Total cases 487
Tale H Outcomes of verification of Scottish cancer registrations
for chikldn 0-14 years, Scotland, 1975-90
Error
Variable frequency
Percentage
Calender year of diagnosis 12 2.8
<12 months 9 2.1
> 12 months 3 0.7
Age atdiagnosis 23 5.4
Incorrent date of birth 7 1.6
Incorrect full date of diagnoses 16 3.7
Sex 2 0.5
Post code 35 8.2
At sector level 17 4.0
Full post code 18 4.2
Surname 7 1.6
Complete differences 2 0.5
Spelling differences 5 1.2CHILDHOOD BRAIN TUMOURS IN SCOTLAND 975
review are shown in Table II. In 12 cases (2.8%, 12/249) the
calendar year of diagnosis was incorrectly recorded.
Examination of the full date showed that 9 of the 12 cases
were inaccurate by less than 12 months. The child's age at
diagnosis was incorrect in 23 cases (5.4%, 23/429), and this
was mainly because of inaccurate recording of the full date of
diagnosis (3.7%, 16/429) rather than date of birth (1.6%,
7/429). Sex and child's surname were in error in less than 1%
of cases. The full post code of address at diagnosis was
incorrect in 35 cases (8.2%, 35/429), although addresses were
coded to a different post code sector in only 17 cases (4.0%,
17/429).
Of the 390 registry cases originally coded to the brain
(ICD-9 191) 378 (97%, 378/390) were correctly coded. The
remaining 12 comprised one eye tumour, one endocrine
tumour, one endocrine tumour of uncertain behaviour, one
lymphoma, one benign brain tumour, one neoplasm of other
and ill-defined site and six non-neoplastic conditions. Of the
39 registry cases originally coded to ICD-9 192 (other and
unspecified parts of nervous sytem) 25 had histological diag-
noses consistent with the site code, whereas 10 of the remain-
ing 14 were histologically confirmed brain tumours (ICD-9
191). The remaining four cases were reviewed as metastatic
extradural carcinoma (1), bone tumours (2) and non-
neoplastic disease (1).
In total, there remained 413 validated cases in the ICD-9
range 191-192. Morphology coding for these 413 cases was
correct to the first three digits of ICD-O for 54% (222/413)
of cases. The most common error (92 cases) involved the
misclassification of ICD-O code 942 (pilocytic astrocytoma,
spongioblastoma not otherwise specified (NOS) and spon-
gioblastoma polare) to code 940 (astrocytoma NOS and
astrocytoma, anaplastic type). Table III shows that the
original diagnosis of ghoma was validated for only 36 cases
(52%, 36/69), but ependymomas and medulloblastoma were
generally well recorded by the cancer registration scheme.
Classification
The current standard coding schemes for cancer registration
in the UK are ICD-9 for anatomical site and ICD-O for
morphology. In epidemiological studies of childhood cancer
it is common practice to use a specialised classification
scheme incorporating both site and morphology (Birch &
Marsden, 1987). The Birch and Marsden classification, as
modified by the Childhood Cancer Research Group (C.A.
Stiller, personal communication), incorporates all tumours of
the brain and spinal cord, including those defined as his-
tologically benign. In this latter respect it differs from the
standard UK cancer registry practice which was the subject
of our review. However, in order to present comparable
statistics in our epidemiological review, we reclassified the
487 cases validated to ICD-9 to the modified Birch and
Marsden scheme. A cross-classification of cases in the ICD-9
range 191-192 ('Brain and other CNS tumours') with the
modified Birch and Marsden range 31-35 ('Central nervous
system and miscellaneous intracranial and intraspinal neop-
lasms') is shown in Table IV. Fourteen of the 487 valid
ICD-9 cases were assigned to other Birch and Marsden
categories. The majority of these were ten non-gonadal germ
cell and trophoblastic neoplasms in addition to one sym-
pathetic nervous system tumour, one other and unspecified
malignant bone tumour, one skin carcinoma and one benign
neoplasm of other and unspecified sites. These 14 cases were
excluded from the epidemiological analyses. Twenty-one
cases were introduced from ICD-9 codes other than 191-192
these included 19 endocrine gland tumours, one eye tumour
and one connnective and other soft-tissue tumour. Therefore
a final total of 494 cases of brain and CNS tumours as
defined by the Birch and Marsden codes 31-35 were selected
for further statistical analysis.
In summary, 45 of the 494 cases in this final analysis
grouping were ascertained from the sources other than the
cancer registry. These additional cases were found to be
spread evenly over the study time period (24 cases 1975-82;
21 cases 1983-90). No evidence of a geographical bias in
added cases was present.
D e screipMv
Figure 1 shows the temporal distribution of the annual world
age-standardised incidence rates expressed per million child-
hood (0-14 years) population for both sexes combined. The
rate per million in 1975 was 20.2 (per 1,000,000) and rose to
38.2 in 1990. Although there was year-to-year fluctuation in
rates, there was evidence of a trend of increasing incidence
over time. The average annual percentage change in
incidence rates was estimated as 2.6% (95% confidence inter-
val 0.3-4.9, P = 0.039). Increasing trends were found for all
subgroups, but this was significant only for medulloblas-
tomas (3.4% increase, 95% confidence interval 0.3-6.6,
P = 0.046).
Table V gives the numbers of children registered in each
Table IV Classification of validated cases coded to ICD-9 and the
modified Birch and Marsden scheme
Validated ICD-9
Modified Birch Cancer registration coding
and Marsden
scheme ICD-9 191-192 Other ICD-9 Total
Included in range 31-35 473 21 494
Other B & M code 14 - 14
Total 487 21 (508)
Table m Classification of the ICD-0 codes (first three digits) for the original and validated diagnosis
Validated diagnosis
ICD-O 939 ICD-0 942
Choroid plexus Fibrilarv astrocvtoma
ICD-0 938 Papilloma ICD-O 940 Pilocvtic astrocvtoma ICD-O 947
Original diagnosis Glioma Ependvmoma Astrocvtoma Spongioblastoma Meidloblastoma Other Total
ICD-O 938 Glioma 36 3 7 13 5 5 69
ICD-O 939 Choroid plexus 0 25 0 0 2 3 30
Papilloma
Ependymoma
ICD-O 940 Astrocytoma 11 2 15 92 3 8 131
ICD-O942 Fibrillary asrocytofa 1 0 0 33 0 1 35
Pilocytic astrocytoma
Spongioblastoma
ICD-0 947 Medulloblastoma 0 2 0 0 104 1 107
Other 4 7 3 3 9 15 41
Total 52 39 25 141 123 33 4139176 P.A. McKINNEY et al.
diagnostic subgroup along with their crude and world stan-
dardised incidence rates. Overall, astrocytomas were the
largest group (42% 209/494) and with the medulloblastomas
(27%, 134/494) constituted almost 70% of cases. The propor-
tions of astrocytomas and medulloblastomas did not vary by
age at diagnosis. Ependymomas (10% of all cases) occurred
more frequently in children under 5 years. Differences by sex
were evident for astrocytomas with a female predominance
overall (1:1.4), and for medulloblastomas there was a male
excess (1.6:1). For astrocytomas the age groups 1-4 and 5-9
showed the highest female-male sex ratios of 1.8 and 1.7
respectively.
For all brain and CNS tumours the age-specific incidence
was 20.1 for children under 1 year, with rates per million of
33.3, 31.5 and 24.1 in the 1-4, 5-9 and 10-14 age groups
respectively.
Standardised registration ratios (SRRs) for health board
areas in Scotland, for all tumour types and age groups
combined, are shown in Figure 2. There was substantial
variation in the incidence of brain and CNS tumours across
Scotland (chi-squared 47.3, d.f. 12, P<0.001). Children resi-
dent in Fife and Lothian Health Board areas experienced
incidence rates which were 56% and 38% greater than
expected from national rates, while rates in Grampian were
lower than expected.
Figure 3 presents world age-standardised incidence rates
per million for five categories of the Carstairs deprivation
score. The highest incidence was observed among children
resident in the most affluent areas, with a rate per million of
35.1, at least 37% higher than incidence in the two categories
representing the least affluent areas. A statistically significant
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Figue 1 World age-standardised incidence rates (per 1,000,000
population) of CNS and miscellaneous intracranial and intras-
pinal neoplasms by year of diagnosis for children 0-14 years,
Scotland. 1975-90.
linear trend was observed (P = 0.005). The association with
affluent areas was accounted for by the astrocytomas (linear
trend p = 0.004) with the other subgroups failing to reach
significance.
Doas
The main purpose of our investigation was to provide a
complete and accurate set of data on childhood cancers in
order to examine small-scale geographical distributions
around designated nuclear facilities in Scotland. An integral
part of this exercise was to verify demographic details of the
cases, including residence at time of diagnosis, and to
validate the diagnosis. The starting point was listings from
the Scottish Cancer Registry, thus enabling optimisation of
ascertaiment and accuracy of cancer registrations for a sub-
group of childhood cancers recorded with brain and CNS
tumours. The case verification and validation exercise has
shown that only 1.8% (8/442) of cancer registry cases were
invalid in our sample as a result of non-diagnostic factors
such as duplication. The careful and systematic pathological
review of diagnosis revealed that 3.7% (16/429) of cases
should not have been assigned to the ICD-9 codes 191-192.
Misclassification of histological coding was evident for those
with a correct site code, although the influence of this on
standard cancer registration statistics would be minimal. A
local audit of the quality of cancer registration data in
Tayside Health Board, Scotland, showed that 4% of all cases
of cancer were assigned an incorrect ICD-9 code (Lapham &
Waugh, 1992), and our findings are consistent with this. An
earlier Scottish study which validated childhood leukaemias
from the Scottish Cancer Registry found a higher percentage
(7%) of misdiagnosed cases (Glass et al., 1987). A recent
study in The Netherlands also showed a higher 6% error rate
for registration of primary site (Schouten et al., 1993). The
significance of our results in a small subset would have a
proportionally greater effect on epidemiological analyses.
Population-based disease registers never achieve complete,
i.e. 100%, ascertainment, but using registrations from
differing sources will maximise the number of cases. The
results of the additional case-finding exercises in the current
study caused some concern as 5.7% (28/487) ofincident cases
from the Scottish Cancer Registry defined by ICD-9 191-192
were not registered under the correct code and a further
8.4% (41/487) were not registered at all. For the former
cases, problems with coding using ICD-9 may explain the
inaccuracies. Failure to ascertain such a considerable number
Table V Number of registrations, percentage histologically verified (HV) crude rates and world age-standardised rates of CNS and miscellaneous intracranial and intraspinal neoplasms for children 0-14 years by sex. Scotland, 1975-90
Category 0 1-4 5-9 10-14 0-14 HV (%) Crude rate WASR
Males
Ependymoma 0 13 2 11 26 96.2 2.93 3.06 Astrocytoma 6 23 27 34 90 97.8 10.14 10.17 Medulloblastoma 2 29 27 26 84 97.6 9.47 9.74 Other glioma 0 5 18 9 32 18.8 3.61 3.51 Miscellaneous intracranial and intraspinal 0 4 12 7 23 56.5 2.59 2.52 All CNS 8 74 86 87 255 83.9 28.74 29.01
Females
Ependymoma 4 12 3 4 23 95.7 2.73 3.14 Astrocytoma 5 39 43 32 119 95.8 14.12 14.64 Medulloblastoma 2 10 27 11 50 94.0 5.93 5.99 Other glioma 1 6 13 9 29 13.8 3.44 3.41 Miscellaneous intracranial and intraspinal 1 0 7 10 18 83.3 2.14 1.91 All CNS 13 67 93 66 239 84.5 28.35 29.08
Males and females
Ependymoma 4 25 5 15 49 95.9 2.83 2.83 Astrocytoma 11 62 70 66 209 %.7 12.08 12.35 Medulloblastoma 4 39 54 37 134 96.3 7.74 7.91 Other glioma I 11 31 18 61 16.4 3.53 3.46 Miscellaneous intracranial and intraspinal 1 4 19 17 41 68.3 2.37 2.22 All CNS 21 141 179 153 494 84.2 28.55 29.04
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Figwe 2 Numbers of cases (n). standardised registration ratios (SRRs) of all CNS neoplasms for health board (HB) of residence
for children 0- 14 years, Scotland, 1975-90.
of cases points to inadequacies of the registration system and
methods of case finding. This deficiency is currently being
addresed, and use of computrised data from a vanety of
sources, including pathology departments, will assist in the
future. The fact that the reviewing pathologists were the
primary source of our additional cases appears to support
this. Overall, the errors we have documented are substantial
enough to influence the results of small-area geographical
studies and underline the importance ofvalidating data when
such work is contemplated.
Descriptive epidemiology of childhood brain and CNS
tumours, in common with all other childhood cancers, is
based on a morphologically orientated classification scheme
(Birch & Marsden, 1987), and statistics prepared on cancer
registry data, and therefore coded only by site, may differ.
The use of the Birch and Marsden scheme for our analyses
gave us the most precise classification and facilitates com-
parison with other data sets. Overall, data for the two
different classification schemes were numerically very similar
and large-scale analyses would produce similar results from
either data set Pathological classification systems identify
2984
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Fgwe 3 World age-&tandardised rates (per 1,000,000 popula-
tion) for CNS and miscellaneous intracranial and intraspinal
neoplasms by deprivation category for children 0- 14 years, Scot-
land, 1975-90.
rare groups of tumours which may be aetiologically distinct
but have to be subsumed into larger groups for descriptive
analyses. The potential for trends in incidence of rare
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tumours to be masked by results from larger subgroups is
always present. The scheme for classifying childhood brain
tumours incorporates five subgroups, and inevitably specific
unusual tumours are too few in numbers to be examined
separately.
The age-standardised incidence rates for our validated
Scottish data are higher (29.0 per million) than those
previously published (21.2 per million) (Parkin et al., 1988a),
which may be accounted for either by previous underascer-
tainment or by a isein incidence. This higher rate puts
Scotland close to the Scandiavian countres, which display
the highest incidence in Europe: Sweden, 34.9 per million
(Lannering et al., 1990); Finland, 31.2 per million; and Den-
mark, 30.9 per million (Parkin et al., 1988a). These are at
least 50% higher than observed rates in Hungary (18.4 per
million) (Parkin et al., 1988a). Incidence in the north of
England for an earlier time period (1968-82) gives a crude
intermediate rate of 25.7 per million (Craft et al., 1987). The
relative frequency of the diagnostic subgroups reflects the
pattern of other population-based studies (Parkin et al.,
1988a, Kallio et al., 1991). The diffculties associated with the
ascertainment of brain tumours and the fact that analysis of
validated data gives rise to increased rates, as shown by our
and other studies (Lannering et al., 1990), suggests that
published incidence figures based on cancer registration may
be conservative. Sex ratios for the two most common subg-
roups oftumours, astrocytoma and medulloblastoma, show a
female and a male excess respectively. For medulloblastomas
this is consistent with international data (Parkin et al.,
1988b), but the finding for astrocytomas is unusual compared
with other countries where sex ratios are generally close to
unity. In the Scottish data the effect is most marked in the
1-9 year age group, however no explanation is immediately
apparent for these observations.
Temporal trends in incidence for childhood brain tumours
have received little attention in the literature, which makes
comparison of the Scottish finding of a significant increase
difficult to set in the context of other countries. In this group
of tumours, changes in diagnostic practice over time have
been substantial, and an increase in numbers could be
explained by improved availability of biopsy material for
histological diagnosis. The reasons for suggesting the rise is
real rather than artefactual are 2-fold. Firstly, the proportion
of 'other and unspecified tumours' has not decreased to the
same extent over the time period (1975, 15.4%; 1990, 8.1%)
and neither has the proportion of histologically verified
tumours changed (1975, 84.6%; 1990, 91.9%). The partic-
ularly prominent increase in incidence is ptially dependent
on the low incidence rates in the early years of the study,
however there is no evidence to suggest that ascertainment
was especially poor in this early period.
Published scientific and medical literature does not appear
to document geographical differences, particuly within a
country, in incidence for this group of childhood malignan-
cies. In Scotland significant variation exists by health board
area, although the confidence intervals on the areas showing
the significant excesses and deficits are wide. These results
should be interpreted with caution. The methods used to
optimise case ascertainment cross-checked sources which
covered the whole of Scotland, and there is no evidence to
suggest that levels of asertainment differ by geographical
region. The four neuropathology centres in Scotland receive
cross-boundary referrals which do not necessarily relate to
the proximity of the cases' residences at diagnosis. The
reason for this geographical heterogeneity is difficult to ex-
plain in relation to environmental risk factors as so little
analytical work has been done in this field. Visual inspection
of the health board map of Scotland and accompanying
SRRs (Figure 2) suggests a tendency for rural and sparsely
populated area, particularly in the North, to have SRRs
lower than 100. However, this, is not the case in the Borders
and Dumfries and Galloway, where high SRRs are present.
To confirm a tentative indication of increasing incidence
moving from the north of Scotland to the south would
require detailed areal studies adjusting for a variety of fac-
tors, including differentials in underlying incidence rates. The
interpretation of our current observations is therefore
limited.
Socioeconomic status and its relationship to childhood
brain and CNS tumours and area of residence seems not to
have been investigated elsewhere. Ecological correlation
studies always have limitations in that they characterise an
area and not an individual with the disease. A review of
case-control studies investigating childhood brain tumours
(Kuijten & Bunin 1993) reported two studies showing a
positive association for parental 'professional occupations'
and higher social class, which is consistent with the Scottish
findings. Two fuirther studies (Kuijten & Bnin, 1993) and
one recent study (McCredie et al., 1994) observed reduced
levels of education in the parents of case children. The newly
described association with higher social groups found in the
present study requires confirmation from other independent
data sets. However, the strength of the association means
that future statistical analysis of distribution should account
for socioeconomic status. The study findings of variation in
incidence by both health board area and deprivation category
appear to be independent of each other on preliminary
examination of the data. Areas with a high proportion of
post code sectors in the most affluent Carstairs category are
not necesarily those with SRRs greater than 100. Similarly,
those with high proportions of post code sectors in the most
deprived category (e.g. Greater Glasgow) do not necessarily
have low SRRs. The relationship between geographical area
and socioeconomic level is currently being investigated.
In conclusion, we have demonstrated a requirement for
validation of cancer registry data to be employed in detailed
studies of geographical distnbution where few cases can
influence results. These types of studies should also consider
taling socioeconomic levels into account.
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